<DOC>
	<DOCNO>NCT00807872</DOCNO>
	<brief_summary>The purpose study determine capability radiolabeled amyloid-reactive monoclonal antibody document presence distribution amyloid deposit PET/CT image patient AL amyloidosis .</brief_summary>
	<brief_title>Radioimmunoimaging AL Amyloidosis</brief_title>
	<detailed_description>To eligible study , patient must confirm diagnosis AL amyloidosis without significant cardiac ( New York Heart Association class IV ) disease kidney dialysis . Additionally , test , blood must contain antibody mouse protein . The study require intravenous infusion , give 10 minute , radiolabeled antibody , follow 48 hour later PET/CT scan . A repeat scan do 5 7 day infusion antibody . A 5 ml blood specimen need furnished 4 8 week antibody infusion .</detailed_description>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Confirmed diagnosis AL amyloidosis New York Heart Association class IV patient renal dialysis serum antibody mouse protein</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Radioimmunoimaging</keyword>
	<keyword>AL Amyloidosis</keyword>
	<keyword>PET/CT</keyword>
</DOC>